← The SEC Ephemeris: the whole map
Ipsen Biopharm Ltd. relabotulinumtoxin A
In the graph: all 1 documents (3 pages).
- Application
- BLA 761311
- Ticker
- Ipsen Biopharm Ltd.
- Product
- relabotulinumtoxin A
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- June 29, 2026
From FDA letters and SEC filings. Not investment or medical advice.